Related references
Note: Only part of the references are listed.VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway
Guangyan Zhangyuan et al.
ONCOGENE (2020)
Applications of Network Pharmacology in Traditional Chinese Medicine Research
Zhuchen Zhou et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
Thomas G. Cotter et al.
GASTROENTEROLOGY (2020)
Tumour evolution in hepatocellular carcinoma
Amanda J. Craig et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Vorinostat upregulates MICA via the PI3K/Akt pathway to enhance the ability of natural killer cells to kill tumor cells
Chenglai Xia et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Using Traditional Chinese Medicine to Treat Hepatocellular Carcinoma by Targeting Tumor Immunity
Wentao Jia et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)
Quercetin potentializes the respective cytotoxic activity of gemcitabine or doxorubicin on 3D culture of AsPC-1 or HepG2 cells, through the inhibition of HIF-1α and MDR1
Sarah Hassan et al.
PLOS ONE (2020)
ADMET modeling approaches in drug discovery
Leonardo L. G. Ferreira et al.
DRUG DISCOVERY TODAY (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Targeted therapy for hepatocellular carcinoma: Challenges and opportunities
Shuzhen Chen et al.
CANCER LETTERS (2019)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice
Hongguang Xia et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
Hua Luo et al.
CHINESE MEDICINE (2019)
Targeted and Immune-Based Therapies for Hepatocellular Carcinoma
Tim F. Greten et al.
GASTROENTEROLOGY (2019)
A review on traditional uses, phytochemistry and pharmacology of Eclipta prostrata (L.) L.
Li Feng et al.
JOURNAL OF ETHNOPHARMACOLOGY (2019)
Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma
Ying Wen et al.
ONCOGENE (2019)
Hypoxia regulates the mitochondrial activity of hepatocellular carcinoma cells through HIF/HEY1/PINK1 pathway
David Kung-Chun Chiu et al.
CELL DEATH & DISEASE (2019)
Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells
Jiali Yang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Exploring the Mechanism of Danshen against Myelofibrosis by Network Pharmacology and Molecular Docking
Jie Li et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)
Different Survival Benefits of Chinese Medicine for Pancreatic Cancer: How to Choose?
Meng Li et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2018)
Molecular inflation, attrition and the rule of five
Paul D. Leeson
ADVANCED DRUG DELIVERY REVIEWS (2016)
Diet-induced non-alcoholic fatty liver disease affects expression of major cytochrome P450 genes in a mouse model
Tsuyoshi Chiba et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2016)
Hepatocellular carcinoma: From diagnosis to treatment
Miral Sadaria Grandhi et al.
SURGICAL ONCOLOGY-OXFORD (2016)
A Fibroblast Growth Factor 21-Pregnane X Receptor Pathway Downregulates Hepatic CYP3A4 in Nonalcoholic Fatty Liver Disease
Sarah J. Woolsey et al.
MOLECULAR PHARMACOLOGY (2016)
Nonalcoholic Fatty Liver Disease A Systematic Review
Mary E. Rinella
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Network Pharmacology in Traditional Chinese Medicine
Shao Li et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Inhibitory effect of Ecliptae herba extract and its component wedelolactone on pre-osteoclastic proliferation and differentiation
Yan-Qiu Liu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2014)
MUC15 Inhibits Dimerization of EGFR and PI3K-AKT Signaling and Is Associated With Aggressive Hepatocellular Carcinomas in Patients
Ruo-Yu Wang et al.
GASTROENTEROLOGY (2013)
Identification and evaluation of anti Hepatitis C virus phytochemicals from Eclipta alba
Dinesh Manvar et al.
JOURNAL OF ETHNOPHARMACOLOGY (2012)
Regulation of Hepatic Cytochromes P450 by Lipids and Cholesterol
Mateja Hafner et al.
CURRENT DRUG METABOLISM (2011)
Evaluation of hydro-alcoholic extract of Eclipta alba for its anticancer potential: An in vitro study
Harshita Chaudhary et al.
JOURNAL OF ETHNOPHARMACOLOGY (2011)
Physiochemical drug properties associated with in vivo toxicological outcomes
Jason D. Hughes et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Preliminary immunomodulatory activities of methanol extracts of Eclipta alba and Centella asiatica
MG Jayathirtha et al.
PHYTOMEDICINE (2004)
Share Paper
